[1]
|
Ensrud, K.E. and Crandall, C.J. (2017) Osteoporosis. Annals of Internal Medicine, 167, ITC17-ITC32.
https://doi.org/10.7326/AITC201708010
|
[2]
|
Johnston, C.B. and Dagar, M. (2020) Osteoporosis in Older Adults. The Medical clinics of North America, 104, 873-884. https://doi.org/10.1016/j.mcna.2020.06.004
|
[3]
|
Cotts, K.G. and Cifu, A.S. (2018) Treatment of Osteoporosis. JAMA, 319, 1040-1041.
https://doi.org/10.1001/jama.2017.21995
|
[4]
|
Zhong, D., Xu, G.-Z., Wu, J.-Z., et al. (2021) Circ-ITCH Sponges miR-214 to Promote the Osteogenic Differentiation in Osteoporosis via Upregulating YAP1. Cell Death & Disease, 12, Article No. 340.
https://doi.org/10.1038/s41419-021-03586-y
|
[5]
|
Jin, F., Li, J., Zhang, Y.-B., et al. (2021) A functional Motif of Long Noncoding RNA Nron against Osteoporosis. Nature Communications, 12, Article No. 3319. https://doi.org/10.1038/s41467-021-23642-7
|
[6]
|
Hosseinkhani, B., van den Akker, N.M.S., Molin, D.G.M., et al. (2020) (Sub)Populations of Extracellular Vesicles Released by TNF-α -Triggered Human Endothelial Cells Promote Vascular Inflammation and Monocyte Migration. Journal of Extracellular Vesicles, 9, Article ID: 1801153. https://doi.org/10.1080/20013078.2020.1801153
|
[7]
|
Yao, F., Xue, Q., Li, K., et al. (2019) Phenolic Compounds and Ginsenosides in Ginseng Shoots and Their Antioxidant and Anti-Inflammatory Capacities in LPS-Induced RAW264.7 Mouse Macrophages. International Journal of Molecular Sciences, 20, Article No. 2951. https://doi.org/10.3390/ijms20122951
|
[8]
|
Zhu, N. and Hou, J. (2021) Molecular Mechanism of the Anti-Inflammatory Effects of Sophorae Flavescentis Aiton identified by network pharmacology. Scientific Reports, 11, Article No. 1005.
https://doi.org/10.1038/s41598-020-80297-y
|
[9]
|
Kany, S., Vollrath, J.T. and Relja, B. (2019) Cytokines in Inflammatory Disease. International Journal of Molecular sciences, 20, Article No. 6008. https://doi.org/10.3390/ijms20236008
|
[10]
|
Besedovsky, L., Lange, T. and Haack, M. (2019) The Sleep-Immune Crosstalk in Health and Disease. Physiological Reviews, 99, 1325-1380. https://doi.org/10.1152/physrev.00010.2018
|
[11]
|
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867.
https://doi.org/10.1038/nature01322
|
[12]
|
Campisi, J. (2005) Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors. Cell, 120, 513-522. https://doi.org/10.1016/j.cell.2005.02.003
|
[13]
|
Mantovani, A., Allavena, P., Sica, A., et al. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[14]
|
Kuilman, T., Michaloglou, C., Vredeveld, L.C.W., et al. (2008) Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network. Cell, 133, 1019-1031. https://doi.org/10.1016/j.cell.2008.03.039
|
[15]
|
Acosta, J.C., O’Loghlen, A., Banito, A., et al. (2008) Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell, 133, 1006-1018. https://doi.org/10.1016/j.cell.2008.03.038
|
[16]
|
Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, Inflammation, and Cancer. Cell, 140, 883-899. https://doi.org/10.1016/j.cell.2010.01.025
|
[17]
|
Murakami, M., Harada, M., Kamimura, D., et al. (2013) Disease-Association Analysis of an Inflammation-Related Feedback Loop. Cell Reports, 3, 946-959. https://doi.org/10.1016/j.celrep.2013.01.028
|
[18]
|
Napimoga, M.H., Dantas Formiga, W.D., Abdalla, H.B., et al. (2020) Secreted Osteoclastogenic Factor of Activated T Cells (SOFAT) Is Associated With Rheumatoid Arthritis and Joint Pain: Initial Evidences of a New Pathway. Frontiers in Immunology, 11, Article No. 1442. https://doi.org/10.3389/fimmu.2020.01442
|
[19]
|
Liu, Y., Wang, Z., Ma, C., et al. (2020) Dracorhodin Perchlorate Inhibits Osteoclastogenesis through Repressing Rankl-Stimulated Nfatc1 Activity. Journal of Cellular and Molecular Medicine, 24, 3303-3313.
https://doi.org/10.1111/jcmm.15003
|
[20]
|
Saylor, P.J., Lee, R.J. and Smith, M.R. (2011) Emerging Therapies to Prevent Skeletal Morbidity in Men with Prostate Cancer. Journal of Clinical Oncology, 29, 3705-3714. https://doi.org/10.1200/JCO.2010.34.4994
|
[21]
|
Dinarello, C.A. and Wolff, S.M. (1993) The Role of Interleukin-1 in Disease. The New England Journal of Medicine, 328, 106-113. https://doi.org/10.1056/NEJM199301143280207
|
[22]
|
Borish, L.C. and Steinke, J.W. (2003) 2. Cytokines and Chemokines. The Journal of Allergy and Clinical Immunology, 111, S460-S475. https://doi.org/10.1067/mai.2003.108
|
[23]
|
Dinarello, C.A. (2011) Interleukin-1 in the Pathogenesis and Treatment of Inflammatory Diseases. Blood, 117, 3720-3732.
https://doi.org/10.1182/blood-2010-07-273417
|
[24]
|
Cerretti, D.P., Kozlosky, C.J., Mosley, B., et al. (1992) Molecular Cloning of the Interleukin-1 Beta Converting Enzyme. Science, 256, 97-100. https://doi.org/10.1126/science.1373520
|
[25]
|
Pichery, M., Mirey, E., Mercier, P., et al. (2012) Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain. Journal of Immunology, 188, 3488-3495. https://doi.org/10.4049/jimmunol.1101977
|
[26]
|
Schmitz, J., Owyang, A., Oldham, E., et al. (2005) IL-33, an Interleukin-1-Like Cytokine That Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity, 23, 479-490.
https://doi.org/10.1016/j.immuni.2005.09.015
|
[27]
|
McCarthy, D.A., Ranganathan, A., Subbaram, S., et al. (2013) Redox-Control of the Alarmin, Interleukin-1α. Redox Biology, 1, 218-225. https://doi.org/10.1016/j.redox.2013.03.001
|
[28]
|
Kim, B., Lee, Y., Kim, E., et al. (2013) The Interleukin-1α Precursor is Biologically Active and Is Likely a Key Alarmin in the IL-1 Family of Cytokines. Frontiers in Immunology, 4, Article No. 391.
https://doi.org/10.3389/fimmu.2013.00391
|
[29]
|
Gross, O., Yazdi, A.S., Thomas, C.J., et al. (2012) Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1. Immunity, 36, 388-400.
https://doi.org/10.1016/j.immuni.2012.01.018
|
[30]
|
Liu, X., Zhang, Z., Ruan, J., et al. (2016) Inflammasome-Activated Gasdermin D Causes Pyroptosis by Forming Membrane Pores. Nature, 535, 153-158. https://doi.org/10.1038/nature18629
|
[31]
|
Sborgi, L., Rühl, S., Mulvihill, E., et al. (2016) GSDMD Membrane Pore Formation Constitutes the Mechanism of Pyroptotic Cell Death. The EMBO Journal, 35, 1766-1778. https://doi.org/10.15252/embj.201694696
|
[32]
|
Shi, J., Zhao, Y., Wang, K., et al. (2015) Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death. Nature, 526, 660-665. https://doi.org/10.1038/nature15514
|
[33]
|
Zheng, Y., Humphry, M., Maguire, J.J., et al. (2013) Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation. Immunity, 38, 285-295.
https://doi.org/10.1016/j.immuni.2013.01.008
|
[34]
|
Dinarello, C.A. (2009) Immunological and Inflammatory Functions of the Interleukin-1 Family. Annual Review of Immunology, 27, 519-550. https://doi.org/10.1146/annurev.immunol.021908.132612
|
[35]
|
Netea, M.G., Nold-Petry, C.A., Nold, M.F., et al. (2009) Differential Requirement for the Activation of the Inflammasome for Processing and Release of IL-1beta in Monocytes and Macrophages. Blood, 113, 2324-2335.
https://doi.org/10.1182/blood-2008-03-146720
|
[36]
|
Agostini, L., Martinon, F., Burns, K., et al. (2004) NALP3 Forms an IL-1beta-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder. Immunity, 20, 319-325.
https://doi.org/10.1016/S1074-7613(04)00046-9
|
[37]
|
Weber, A., Wasiliew, P. and Kracht, M. (2010) Interleukin-1 (IL-1) Pathway. Science Signaling, 3, cm1.
https://doi.org/10.1126/scisignal.3105cm1
|
[38]
|
Di Paolo, N.C., Shafiani, S., Day, T., et al. (2015) Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection. Immunity, 43, 1125-1136.
https://doi.org/10.1016/j.immuni.2015.11.016
|
[39]
|
Bersudsky, M., Luski, L., Fishman, D., et al. (2014) Non-Redundant Properties of IL-1α and IL-1β during Acute Colon Inflammation in Mice. Gut, 63, 598-609. https://doi.org/10.1136/gutjnl-2012-303329
|
[40]
|
Freigang, S., Ampenberger, F., Weiss, A., et al. (2013) Fatty Acid-Induced Mitochondrial Uncoupling Elicits Inflammasome-Independent IL-1α and Sterile Vascular Inflammation in Atherosclerosis. Nature Immunology, 14, 1045-1053.
https://doi.org/10.1038/ni.2704
|
[41]
|
Brough, D. and Denes, A. (2015) Interleukin-1α and Brain Inflammation. IUBMB Life, 67, 323-330.
https://doi.org/10.1002/iub.1377
|
[42]
|
Garlanda, C., Dinarello, C.A. and Mantovani, A. (2013) The Interleukin-1 Family: Back to the Future. Immunity, 39, 1003-1018. https://doi.org/10.1016/j.immuni.2013.11.010
|
[43]
|
Ge, Y., Huang, M. and Yao, Y.-M. (2019) Recent Advances in the Biology of IL-1 Family Cytokines and Their Potential Roles in Development of Sepsis. Cytokine & Growth Factor Reviews, 45, 24-34.
https://doi.org/10.1016/j.cytogfr.2018.12.004
|
[44]
|
Teitelbaum, S.L. (2000) Bone Resorption by Osteoclasts. Science, 289, 1504-1508.
https://doi.org/10.1126/science.289.5484.1504
|
[45]
|
Nakamura, I. and Jimi, E. (2006) Regulation of Osteoclast Differentiation and Function by Interleukin-1. Vitamins and Hormones, 74, 357-370. https://doi.org/10.1016/S0083-6729(06)74015-8
|
[46]
|
Zupan, J., Komadina, R. and Marc, J. (2012) The Relationship between Osteoclastogenic and Anti-Osteoclastogenic Pro-Inflammatory Cytokines Differs in Human Osteoporotic and Osteoarthritic Bone Tissues. Journal of Biomedical Science, 19, Article No. 28. https://doi.org/10.1186/1423-0127-19-28
|
[47]
|
Kudo, O., Fujikawa, Y., Itonaga, I., et al. (2002) Proinflammatory Cytokine (TNFalpha/IL-1alpha) Induction of Human Osteoclast Formation. The Journal of Pathology, 198, 220-227. https://doi.org/10.1002/path.1190
|
[48]
|
Lacativa, P.G.S. and Farias, M.L.F.d. (2010) Osteoporosis and Inflammation. Arquivos Brasileiros de Endocrinologia e Metabologia, 54, 123-132. https://doi.org/10.1590/S0004-27302010000200007
|
[49]
|
Kim, J.H., Jin, H.M., Kim, K., et al. (2009) The Mechanism of Osteoclast Differentiation Induced by IL-1. Journal of immunology, 183, 1862-1870. https://doi.org/10.4049/jimmunol.0803007
|
[50]
|
Zwerina, J., Redlich, K., Polzer, K., et al. (2007) TNF-Induced Structural Joint Damage Is Mediated by IL-1. Proceedings of the National Academy of Sciences of the United States of America, 104, 11742-11747.
https://doi.org/10.1073/pnas.0610812104
|
[51]
|
Weitzmann, M.N. and Pacifici, R. (2005) The Role of T Lymphocytes in Bone Metabolism. Immunological Reviews, 208, 154-168. https://doi.org/10.1111/j.0105-2896.2005.00324.x
|
[52]
|
Guo, C., Yang, X.-G., Wang, F., et al. (2016) IL-1α Induces Apoptosis and Inhibits the Osteoblast Differentiation of MC3T3-E1 Cells through the JNK and p38 MAPK Pathways. International Journal of Molecular Medicine, 38, 319-327. https://doi.org/10.3892/ijmm.2016.2606
|
[53]
|
Speziani, C., Rivollier, A., Gallois, A., et al. (2007) Murine Dendritic Cell Transdifferentiation into Osteoclasts Is Differentially Regulated by Innate and Adaptive Cytokines. European Journal of Immunology, 37, 747-757.
https://doi.org/10.1002/eji.200636534
|
[54]
|
Carriere, V., Roussel, L., Ortega, N., et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 Receptor, Is a Chromatin-Associated Nuclear Factor in Vivo. Proceedings of the National Academy of Sciences of the United States of America, 104, 282-287. https://doi.org/10.1073/pnas.0606854104
|
[55]
|
Molofsky, A.B., Savage, A.K. and Locksley, R.M. (2015) Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity, 42, 1005-1019. https://doi.org/10.1016/j.immuni.2015.06.006
|
[56]
|
Catalan-Dibene, J., McIntyre, L.L. and Zlotnik, A. (2018) Interleukin 30 to Interleukin 40. Journal of Interferon & Cytokine Research, 38, 423-439. https://doi.org/10.1089/jir.2018.0089
|
[57]
|
Dattagupta, A. and Immaneni, S. (2018) ST2: Current Status. Indian Heart Journal, 70, S96-S101.
https://doi.org/10.1016/j.ihj.2018.03.001
|
[58]
|
Villarreal, D.O. and Weiner, D.B. (2014) Interleukin 33: A Switch-Hitting Cytokine. Current Opinion in Immunology, 28, 102-106. https://doi.org/10.1016/j.coi.2014.03.004
|
[59]
|
Lin, W., Zhou, Q., Liu, C., et al. (2017) Increased Plasma IL-17, IL-31, and IL-33 Levels in Chronic Spontaneous Urticaria. Scientific Reports, 7, Article No. 17797. https://doi.org/10.1038/s41598-017-18187-z
|
[60]
|
Perrigoue, J.G., Li, J., Zaph, C., et al. (2007) IL-31-IL-31R Interactions Negatively Regulate Type 2 Inflammation in the Lung. The Journal of Experimental Medicine, 204, 481-487. https://doi.org/10.1084/jem.20061791
|
[61]
|
Guarneri, F., Minciullo, P.L., Mannucci, C., et al. (2015) IL-31 and IL-33 Circulating Levels in Allergic Contact Dermatitis. European Annals of Allergy and Clinical Immunology, 47, 156-158.
|
[62]
|
Murdaca, G., Greco, M., Tonacci, A., et al. (2019) IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases. International Journal of Molecular Sciences, 20, Article No. 5856. https://doi.org/10.3390/ijms20235856
|
[63]
|
Zeng, X., Zhang, Z., Gao, Q.-Q., et al. (2016) Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study. Disease Markers, 2016, Article ID: 9262919.
https://doi.org/10.1155/2016/9262919
|
[64]
|
Miller, A.M. (2011) Role of IL-33 in Inflammation and Disease. Journal of Inflammation, 8, Article No. 22.
https://doi.org/10.1186/1476-9255-8-22
|
[65]
|
Macari, S., Madeira, M.F.M., Lima, I.L.A., et al. (2018) ST2 Regulates Bone Loss in a Site-Dependent and Estrogen-Dependent Manner. Journal of Cellular Biochemistry, 119, 8511-8521. https://doi.org/10.1002/jcb.27080
|
[66]
|
Hirano, T. (1998) Interleukin 6 and Its Receptor: Ten Years Later. International Reviews of Immunology, 16, 249-284.
https://doi.org/10.3109/08830189809042997
|
[67]
|
Hunter, C.A. and Jones, S.A. (2015) IL-6 as a Keystone Cytokine in Health and Disease. Nature Immunology, 16, 448-457. https://doi.org/10.1038/ni.3153
|
[68]
|
Hasegawa, H., Mizoguchi, I., Chiba, Y., et al. (2016) Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family. Frontiers in Immunology, 7, Article No. 479.
https://doi.org/10.3389/fimmu.2016.00479
|
[69]
|
Schaper, F. and Rose-John, S. (2015) Interleukin-6: Biology, Signaling and Strategies of Blockade. Cytokine & Growth Factor Reviews, 26, 475-487. https://doi.org/10.1016/j.cytogfr.2015.07.004
|
[70]
|
Hibi, M., Murakami, M., Saito, M., et al. (1990) Molecular Cloning and Expression of an IL-6 Signal Transducer, gp130. Cell, 63, 1149-1157. https://doi.org/10.1016/0092-8674(90)90411-7
|
[71]
|
Heinrich, P.C., Behrmann, I., Haan, S., et al. (2003) Principles of Interleukin (IL)-6-Type Cytokine Signalling and Its Regulation. The Biochemical Journal, 374, 1-20. https://doi.org/10.1042/bj20030407
|
[72]
|
Radtke, S., Wüller, S., Yang, X.-P., et al. (2010) Cross-Regulation of Cytokine Signalling: Pro-Inflammatory Cytokines Restrict IL-6 Signalling through Receptor Internalisation and Degradation. Journal of Cell Science, 123, 947-959.
https://doi.org/10.1242/jcs.065326
|
[73]
|
Boulanger, M.J., Chow, D.-C., Brevnova, E.E., et al. (2003) Hexameric Structure and Assembly of the Interleukin-6/IL-6 Alpha-Receptor/gp130 Complex. Science, 300, 2101-2104. https://doi.org/10.1126/science.1083901
|
[74]
|
Franchimont, N., Lambert, C., Huynen, P., et al. (2005) Interleukin-6 Receptor Shedding Is Enhanced by Interleukin-1beta and Tumor Necrosis Factor Alpha and Is Partially Mediated by Tumor Necrosis Factor Alpha-Converting Enzyme in Osteoblast-Like Cells. Arthritis and Rheumatism, 52, 84-93. https://doi.org/10.1002/art.20727
|
[75]
|
Walev, I., Vollmer, P., Palmer, M., et al. (1996) Pore-Forming Toxins Trigger Shedding of Receptors for Interleukin 6 and Lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America, 93, 7882-7887. https://doi.org/10.1073/pnas.93.15.7882
|
[76]
|
Lust, J.A., Donovan, K.A., Kline, M.P., et al. (1992) Isolation of an mRNA Encoding a Soluble Form of the Human Interleukin-6 Receptor. Cytokine, 4, 96-100. https://doi.org/10.1016/1043-4666(92)90043-Q
|
[77]
|
Rose-John, S. (2018) Interleukin-6 Family Cytokines. Cold Spring Harbor Perspectives in Biology, 10, Article No. a028415. https://doi.org/10.1101/cshperspect.a028415
|
[78]
|
Luna, J.M., Moon, Y.P., Liu, K.M., et al. (2014) High-Sensitivity C-Reactive Protein and Interleukin-6-Dominant Inflammation and Ischemic Stroke Risk: The Northern Manhattan Study. Stroke, 45, 979-987.
https://doi.org/10.1161/STROKEAHA.113.002289
|
[79]
|
Atsumi, T., Singh, R., Sabharwal, L., et al. (2014) Inflammation Amplifier, a New Paradigm in Cancer Biology. Cancer Research, 74, 8-14. https://doi.org/10.1158/0008-5472.CAN-13-2322
|
[80]
|
Hirano, T. and Murakami, M. (2020) COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity, 52, 731-733. https://doi.org/10.1016/j.immuni.2020.04.003
|
[81]
|
Hirano, T. (2010) Interleukin 6 in Autoimmune and Inflammatory Diseases: A Personal Memoir. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 86, 717-730. https://doi.org/10.2183/pjab.86.717
|
[82]
|
Grivennikov, S.I. and Karin, M. (2010) Dangerous Liaisons: STAT3 and NF-kappaB Collaboration and Crosstalk in Cancer. Cytokine & Growth Factor Reviews, 21, 11-19. https://doi.org/10.1016/j.cytogfr.2009.11.005
|
[83]
|
Grupp, S.A., Kalos, M., Barrett, D., et al. (2013) Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia. The New England Journal of Medicine, 368, 1509-1518. https://doi.org/10.1056/NEJMoa1215134
|
[84]
|
Heinrich, P.C., Castell, J.V. and Andus, T. (1990) Interleukin-6 and the Acute Phase Response. The Biochemical Journal, 265, 621-636. https://doi.org/10.1042/bj2650621
|
[85]
|
Gillmore, J.D., Lovat, L.B., Persey, M.R., et al. (2001) Amyloid Load and Clinical Outcome in AA Amyloidosis in Relation to Circulating Concentration of Serum Amyloid A Protein. Lancet, 358, 24-29.
https://doi.org/10.1016/S0140-6736(00)05252-1
|
[86]
|
Korn, T., Bettelli, E., Oukka, M., et al. (2009) IL-17 and Th17 Cells. Annual Review of Immunology, 27, 485-517.
https://doi.org/10.1146/annurev.immunol.021908.132710
|
[87]
|
Bettelli, E., Carrier, Y., Gao, W., et al. (2006) Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells. Nature, 441, 235-238. https://doi.org/10.1038/nature04753
|
[88]
|
Kimura, A. and Kishimoto, T. (2010) IL-6: Regulator of Treg/Th17 Balance. European Journal of Immunology, 40, 1830-1835. https://doi.org/10.1002/eji.201040391
|
[89]
|
Hashizume, M., Hayakawa, N. and Mihara, M. (2008) IL-6 Trans-Signalling Directly Induces RANKL on Fibroblast-Like Synovial Cells and Is Involved in RANKL Induction by TNF-alpha and IL-17. Rheumatology, 47, 1635-1640.
https://doi.org/10.1093/rheumatology/ken363
|
[90]
|
Kotake, S., Sato, K., Kim, K.J., et al. (1996) Interleukin-6 and Soluble Interleukin-6 Receptors in the Synovial Fluids from Rheumatoid Arthritis Patients Are Responsible for Osteoclast-Like Cell Formation. Journal of Bone and Mineral Research, 11, 88-95. https://doi.org/10.1002/jbmr.5650110113
|
[91]
|
Poli, V., Balena, R., Fattori, E., et al. (1994) Interleukin-6 Deficient Mice Are Protected from Bone Loss Caused by Estrogen Depletion. The EMBO Journal, 13, 1189-1196. https://doi.org/10.1002/j.1460-2075.1994.tb06368.x
|
[92]
|
Palmqvist, P., Persson, E., Conaway, H.H., et al. (2002) IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-kappa B Ligand, Osteoprotegerin, and Receptor Activator of NF-kappa B in Mouse Calvariae. Journal of Immunology, 169, 3353-3362.
https://doi.org/10.4049/jimmunol.169.6.3353
|
[93]
|
Wong, P.K.K., Quinn, J.M.W., Sims, N.A., et al. (2006) Interleukin-6 Modulates Production of T Lymphocyte-Derived Cytokines in Antigen-Induced Arthritis and Drives Inflammation-Induced Osteoclastogenesis. Arthritis and Rheumatism, 54, 158-168. https://doi.org/10.1002/art.21537
|
[94]
|
Feng, W., Liu, H., Luo, T., et al. (2017) Combination of IL-6 and sIL-6R Differentially Regulate Varying Levels of RANKL-Induced Osteoclastogenesis through NF-κB, ERK and JNK Signaling Pathways. Scientific Reports, 7, Article No. 41411. https://doi.org/10.1038/srep41411
|
[95]
|
De Benedetti, F., Rucci, N., Del Fattore, A., et al. (2006) Impaired Skeletal Development in Interleukin-6-Transgenic Mice: A Model for the Impact of Chronic Inflammation on the Growing Skeletal System. Arthritis and Rheumatism, 54, 3551-3563. https://doi.org/10.1002/art.22175
|
[96]
|
Brat, D.J., Bellail, A.C. and Van Meir, E.G. (2005) The Role of Interleukin-8 and Its Receptors in Gliomagenesis and Tumoral Angiogenesis. Neuro-Oncology, 7, 122-133. https://doi.org/10.1215/S1152851704001061
|
[97]
|
Waugh, D.J.J. and Wilson, C. (2008) The Interleukin-8 Pathway in Cancer. Clinical Cancer Research, 14, 6735-6741.
https://doi.org/10.1158/1078-0432.CCR-07-4843
|
[98]
|
Holmes, W.E., Lee, J., Kuang, W.J., et al. (1991) Structure and Functional Expression of a Human Interleukin-8 Receptor. Science, 253, 1278-1280. https://doi.org/10.1126/science.1840701
|
[99]
|
Murphy, P.M. and Tiffany, H.L. (1991) Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor. Science, 253, 1280-1283. https://doi.org/10.1126/science.1891716
|
[100]
|
Knall, C., Young, S., Nick, J.A., et al. (1996) Interleukin-8 Regulation of the Ras/Raf/Mitogen-Activated Protein Kinase Pathway in Human Neutrophils. The Journal of Biological Chemistry, 271, 2832-2838.
https://doi.org/10.1074/jbc.271.5.2832
|
[101]
|
MacManus, C.F., Pettigrew, J., Seaton, A., et al. (2007) Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells. Molecular Cancer Research, 5, 737-748.
https://doi.org/10.1158/1541-7786.MCR-07-0032
|
[102]
|
Venkatakrishnan, G., Salgia, R. and Groopman, J.E. (2000) Chemokine Receptors CXCR-1/2 Activate Mitogen-Activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells. The Journal of Biological Chemistry, 275, 6868-6875. https://doi.org/10.1074/jbc.275.10.6868
|
[103]
|
Luppi, F., Longo, A.M., de Boer, W.I., et al. (2007) Interleukin-8 Stimulates Cell Proliferation in Non-Small Cell Lung Cancer through Epidermal Growth Factor Receptor Transactivation. Lung Cancer, 56, 25-33.
https://doi.org/10.1016/j.lungcan.2006.11.014
|
[104]
|
Glynn, P.C., Henney, E. and Hall, I.P. (2002) The Selective CXCR2 Antagonist SB272844 Blocks Interleukin-8 and Growth-Related Oncogene-Alpha-Mediated Inhibition of Spontaneous Neutrophil Apoptosis. Pulmonary Pharmacology & Therapeutics, 15, 103-110. https://doi.org/10.1006/pupt.2001.0323
|
[105]
|
Li, A., Dubey, S., Varney, M.L., et al. (2003) IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis. Journal of Immunology, 170, 3369-3376.
https://doi.org/10.4049/jimmunol.170.6.3369
|
[106]
|
Murphy, C., McGurk, M., Pettigrew, J., et al. (2005) Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer. Clinical Cancer Research, 11, 4117-4127. https://doi.org/10.1158/1078-0432.CCR-04-1518
|
[107]
|
Allen, T.C. and Kurdowska, A. (2014) Interleukin 8 and Acute Lung Injury. Archives of pathology & Laboratory Medicine, 138, 266-269. https://doi.org/10.5858/arpa.2013-0182-RA
|
[108]
|
Kobayashi, Y. (2008) The Role of Chemokines in Neutrophil Biology. Frontiers in Bioscience, 13, 2400-2407.
https://doi.org/10.2741/2853
|
[109]
|
Ning, Y., Manegold, P.C., Hong, Y.K., et al. (2011) Interleukin-8 Is Associated with Proliferation, Migration, Angiogenesis and Chemosensitivity in Vitro and in Vivo in Colon Cancer Cell Line Models. International Journal of Cancer, 128, 2038-2049. https://doi.org/10.1002/ijc.25562
|
[110]
|
Kraft, R., Herndon, D.N., Finnerty, C.C., et al. (2015) Predictive Value of IL-8 for Sepsis and Severe Infections after Burn Injury: A Clinical Study. Shock, 43, 222-227. https://doi.org/10.1097/SHK.0000000000000294
|
[111]
|
Al-Daghri, N.M., Yakout, S., Al-Shehri, E., et al. (2014) Inflammatory and Bone Turnover Markers in Relation to PTH and Vitamin D Status among Saudi Postmenopausal Women with and without Osteoporosis. International Journal of Clinical and Experimental Medicine, 7, 3528-3535.
|
[112]
|
Sousa, L.H., Linhares, E.V.M., Alexandre, J.T., et al. (2016) Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis. Journal of Periodontology, 87, 1206-1216.
https://doi.org/10.1902/jop.2016.160075
|
[113]
|
Hu, X., Sun, Y., Xu, W., et al. (2017) Expression of RANKL by Peripheral Neutrophils and Its Association with Bone Mineral Density in COPD. Respirology, 22, 126-132. https://doi.org/10.1111/resp.12878
|
[114]
|
Ouyang, W. and O’Garra, A. (2019) IL-10 Family Cytokines IL-10 and IL-22: From Basic Science to Clinical Translation. Immunity, 50, 871-891. https://doi.org/10.1016/j.immuni.2019.03.020
|
[115]
|
Moore, K.W., Vieira, P., Fiorentino, D.F., et al. (1990) Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI. Science, 248, 1230-1234. https://doi.org/10.1126/science.2161559
|
[116]
|
Moore, K.W., O’Garra, A., de Waal Malefyt, R., et al. (1993) Interleukin-10. Annual Review of Immunology, 11, 165-190. https://doi.org/10.1146/annurev.iy.11.040193.001121
|
[117]
|
Moore, K.W., de Waal Malefyt, R., Coffman, R.L., et al. (2001) Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology, 19, 683-765. https://doi.org/10.1146/annurev.immunol.19.1.683
|
[118]
|
Vieira, P., de Waal-Malefyt, R., Dang, M.N., et al. (1991) Isolation and Expression of Human Cytokine Synthesis Inhibitory Factor cDNA Clones: Homology to Epstein-Barr Virus Open Reading Frame BCRFI. Proceedings of the National Academy of Sciences of the United States of America, 88, 1172-1176. https://doi.org/10.1073/pnas.88.4.1172
|
[119]
|
Ouyang, W., Rutz, S., Crellin, N.K., et al. (2011) Regulation and functions of the IL-10 family of Cytokines in Inflammation and Disease. Annual Review of Immunology, 29, 71-109.
https://doi.org/10.1146/annurev-immunol-031210-101312
|
[120]
|
Sing, A., Rost, D., Tvardovskaia, N., et al. (2002) Yersinia V-Antigen Exploits Toll-Like Receptor 2 and CD14 for Interleukin 10-Mediated Immunosuppression. The Journal of Experimental Medicine, 196, 1017-1024.
https://doi.org/10.1084/jem.20020908
|
[121]
|
Dresner-Pollak, R., Gelb, N., Rachmilewitz, D., et al. (2004) Interleukin 10-Deficient Mice Develop Osteopenia, Decreased Bone Formation, and Mechanical Fragility of Long Bones. Gastroenterology, 127, 792-801.
https://doi.org/10.1053/j.gastro.2004.06.013
|
[122]
|
Rios-Arce, N.D., Dagenais, A., Feenstra, D., et al. (2020) Loss of Interleukin-10 Exacerbates Early Type-1 Diabetes-Induced Bone Loss. Journal of Cellular Physiology, 235, 2350-2365. https://doi.org/10.1002/jcp.29141
|
[123]
|
Salomon, B.L. (2021) Insights into the Biology and Therapeutic Implications of TNF and Regulatory T Cells. Nature Reviews. Rheumatology, 17, 487-504. https://doi.org/10.1038/s41584-021-00639-6
|
[124]
|
Wang, Y., Che, M., Xin, J., et al. (2020) The Role of IL-1β and TNF-α in Intervertebral Disc Degeneration. Biomedicine & Pharmacotherapy, 131, Article ID: 110660. https://doi.org/10.1016/j.biopha.2020.110660
|
[125]
|
Bradley, J.R. (2008) TNF-Mediated Inflammatory Disease. The Journal of Pathology, 214, 149-160.
https://doi.org/10.1002/path.2287
|
[126]
|
Zhang, Q., Li, Z., Zhang, M., et al. (2020) Injectable in Situ Self-Cross-Linking Hydrogels Based on Hemoglobin, Carbon Quantum Dots, and Sodium Alginate for Real-Time Detection of Wound Bacterial Infection and Efficient Postoperative Prevention of Tumor Recurrence. Langmuir, 36, 13263-13273.
https://doi.org/10.1021/acs.langmuir.0c02219
|
[127]
|
Wang, T., He, C. and Yu, X. (2017) Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders. Current Drug Targets, 18, 1664-1675.
https://doi.org/10.2174/1389450118666170104153512
|
[128]
|
Zhang, H., Hilton, M.J., Anolik, J.H., et al. (2014) NOTCH Inhibits Osteoblast Formation in Inflammatory Arthritis via Noncanonical NF-κB. The Journal of Clinical Investigation, 124, 3200-3214. https://doi.org/10.1172/JCI68901
|
[129]
|
Yamazaki, M., Fukushima, H., Shin, M., et al. (2009) Tumor Necrosis Factor Alpha Represses Bone Morphogenetic Protein (BMP) Signaling by Interfering with the DNA Binding of Smads through the Activation of NF-kappaB. The Journal of Biological Chemistry, 284, 35987-35995. https://doi.org/10.1074/jbc.M109.070540
|
[130]
|
Huang, H., Zhao, N., Xu, X., et al. (2011) Dose-Specific Effects of Tumor Necrosis Factor Alpha on Osteogenic Differentiation of Mesenchymal Stem Cells. Cell Proliferation, 44, 420-427.
https://doi.org/10.1111/j.1365-2184.2011.00769.x
|
[131]
|
Takayanagi, H., Kim, S. and Taniguchi, T. (2002) Signaling Crosstalk between RANKL and Interferons in Osteoclast Differentiation. Arthritis Research & Therapy, 4, Article No. S227. https://doi.org/10.1186/ar581
|
[132]
|
Takayanagi, H., Ogasawara, K., Hida, S., et al. (2000) T-Cell-Mediated Regulation of Osteoclastogenesis by Signalling Cross-Talk between RANKL and IFN-Gamma. Nature, 408, 600-605. https://doi.org/10.1038/35046102
|
[133]
|
Yao, Z., Lei, W., Duan, R., et al. (2017) RANKL Cytokine Enhances TNF-Induced Osteoclastogenesis Independently of TNF Receptor Associated Factor (TRAF) 6 by Degrading TRAF3 in Osteoclast Precursors. The Journal of Biological Chemistry, 292, 10169-10179. https://doi.org/10.1074/jbc.M116.771816
|
[134]
|
Kaplan, D.L., Eielson, C.M., Horowitz, M.C., et al. (1996) Tumor Necrosis Factor-Alpha Induces Transcription of the Colony-Stimulating Factor-1 Gene in Murine Osteoblasts. Journal of Cellular Physiology, 168, 199-208.
https://doi.org/10.1002/(SICI)1097-4652(199607)168:1<199::AID-JCP24>3.0.CO;2-1
|
[135]
|
Yao, X., Liu, M., Jin, F., et al. (2020) Comprehensive Analysis of Differentially Expressed Circular RNAs in Patients with Senile Osteoporotic Vertebral Compression Fracture. BioMed Research International, 2020, Article ID: 4951251.
https://doi.org/10.1155/2020/4951251
|